ConclusionsCompared with placebo, buprenorphine implants result in significantly less frequent opioid use, and are non‐inferior to sublingual buprenorphine/naloxone tablets. (Source: Addiction)
Buprenorphine Implants for Treatment of Opioid Dependence: Randomized Comparison to Placebo and Sublingual Buprenorphine/Naloxone
Previous post: Advertising Drugs to Addicts
Next post: FDA OKs New Formula for Addiction Drug